91ÌÒÉ«

Abstract

Pancreatic cancer is the fifth cause of death in developing countries, there are 232,000 new cases every year diagnosed around the world with an incidence of 10.9 by 100,000 people, 37,700 are diagnosed as new cases and 34,000 deaths, only 20% are found at diagnosis and only 5% are resectable. In Mexico, 13,080 new cases are reported every year and it do represent fifth place among males and seventh place for women. 353 pancreatic cancer new patients are admitted every year at Hospital de Oncolog�­a in Mexico. Between 1995 and 2005, there has been reported 75% of pancreatic fistulaes with mortality of 19% and 75% morbidity. Soon it was decided that a three surgeonsâ�� group should get additional training for performing the procedure. Between January 2010 and July 2012, 78 patients were admitted for pancreatoduodenectomy, 28 (35%) of them were not resectable during laparotomy, 4 patients (5%) experienced disease progression. There were 3 (4%) deaths during the immediate postoperative period and the causes were lung embolism, pancreatic-yeyuno anastomosis dehiscencia with sepsis, and mesenteric thrombosis. There were 10 patients with complications (12%) including pancreatico-yeyuno anastomosis dehiscencia in 5 patients, hepato-yeyuno anastomosis dehiscencia in 4 patients and bleeding in 3 patients. The bleeding was between 550 ml and 1000 ml and the average operating time was 6 hours. Hospital staying was between 7 and 10 days and none patient required intensive care unit admission. Survival was 35% at 3 years and recurrence 25%.

Biography

Héctor Martínez-Gómez is serving as an esteemed doctor in Hospital de Oncología National Medical, Center Mexico. He is the recipient of numerous awards for his expert research works in related fields. His research interests reflect in his wide range of publications in various national and international journals.

Email: hectormg2004@me.com